Otonomy Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update Genetics Investing
OncoMed Announces Fourth Quarter and Full Year 2017 Financial Results and Operational Highlights Pharmaceutical Investing
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2017 Financial Results Genetics Investing
Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Highlights Pharmaceutical Investing
Calithera Biosciences Reports Fourth Quarter 2017 Financial Results and Recent Highlights Pharmaceutical Investing
MyoKardia Announces Positive Results from Low-Dose Cohort of Phase 2 PIONEER-HCM Study of Mavacamten in Symptomatic Pharmaceutical Investing
VBL Therapeutics Announces Top-Line Results from Pivotal Phase 3 GLOBE Study Pharmaceutical Investing
